The Cascade
The American Dental Association's October 2025 guidance for patients on these peptides spells out the cascade: GI side effects (nausea, vomiting, reflux) lower the pH inside the mouth, and lower oral pH eats at tooth enamel.
Saliva normally buffers the acid; when saliva drops, the defense drops with it. So the path is peptide → GI side effects → low oral pH → enamel erosion.
The Framing
The "Ozempic teeth" framing names a real cluster of dental problems, but with the wrong cause. The dentist-facing literature treats the issue as preventable through routine dental care and attention to reflux.
There isn't a peptide-specific dental mechanism in the evidence. The chain is the GI side effects.
What this means
References2 sources
How to read these sources
This article uses primary sources and reviews to separate mechanism, human evidence, and context.
- Public Update
ADA News
American Dental AssociationOral care considerations for patients using semaglutide, similar medications Read source
Used Here ForGrounding the teeth and oral-health question in a professional dental-association report on GLP-1 medicines.
Good ForPractical oral-care context from a dental professional body.
Not ForA peer-reviewed causal study; treat as clinical guidance, not trial evidence.
ADA News, American Dental Association, October 23, 2025 - Official Label
FDA-approved prescribing information (Wegovy)
U.S. Food and Drug Administration / Novo NordiskWEGOVY (semaglutide) prescribing information: 6 Adverse Reactions Read source
Used Here ForChecking the gastrointestinal adverse reactions, such as nausea and vomiting, that the approved label lists for semaglutide.
Good ForThe FDA-approved list of adverse reactions and how often they were reported.
Not ForDental or oral-care advice.
FDA-approved labeling, DailyMed (National Library of Medicine), updated June 18, 2026